US Oncology's Innovent Oncology Division Announces First Agreement Between Rocky Mountain Cancer Centers and Colorado Public Employees' Retirement A...( Contract Contains Costs and Impro...),Health

Contract Contains Costs and Improves Patient Outcomes

HOUSTON, Oct. 17 /PRNewswire/ -- Innovent Oncology today announced that US Oncology-affiliated practice Rocky Mountain Cancer Centers (RMCC) has signed an agreement with the Colorado Public Employees' Retirement Association (PERA) to provide Patient Support Services to PERA's retired members undergoing cancer treatment at RMCC. The agreement represents the first occasion of services being offered through Innovent Oncology, which will work with RMCC to support PERA's members.

Innovent Oncology, US Oncology's newest services division, offers payers and oncologists solutions that integrate evidence-based treatment Pathways, patient support services and advance care planning to improve clinical outcomes while addressing costs.

"We're delighted our retirees now have access to these vital patient support services giving them added comfort and encouragement through a very difficult time," said Wendy Tenzyk, Insurance Director for Colorado PERA. "We also expect this program will help us manage overall cancer treatment costs for both our retirees and our plan."

PERA has more than 80,000 retirees statewide. PERA operates a self-insured health plan administered by Anthem Blue Cross and Blue Shield of Colorado that covers 36,000 of those retirees and their dependents, and PERA's agreement with RMCC covers those Anthem members. On average, nearly 1,000 of PERA's Anthem members receive cancer treatment each year. Physicians affiliated with Rocky Mountain Cancer Centers treat approximately half of those patients, and provide care for 40-50% of all cancer patients in Colorado.

"We are very pleased to be working with PERA to support its retired members and their families through our unique approach to improving the patient experience throughout their entire cancer treatment," said Kirby Ryan, national sales director for Innovent Oncology.

Innovent Oncology bundles core services a
'/>"/>